aTyr Pharma, Inc. (ATYR)
3.82
+0.13
(+3.52%)
USD |
NASDAQ |
Nov 20, 16:00
3.80
-0.02
(-0.52%)
After-Hours: 20:00
aTyr Pharma Price to Book Value : 0.2823 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 0.2823 |
| November 19, 2026 | 0.2727 |
| November 18, 2026 | 0.3016 |
| November 17, 2026 | 0.3688 |
| November 16, 2026 | 0.3873 |
| November 13, 2026 | 0.4512 |
| November 12, 2026 | 0.459 |
| November 11, 2026 | 0.5004 |
| November 10, 2026 | 0.5588 |
| November 09, 2026 | 0.5603 |
| November 06, 2026 | 0.4693 |
| November 05, 2026 | 0.4457 |
| November 04, 2026 | 0.4568 |
| November 03, 2026 | 0.49 |
| November 02, 2026 | 0.4649 |
| October 30, 2026 | 0.3651 |
| October 29, 2026 | 0.3969 |
| October 28, 2026 | 0.3796 |
| October 27, 2026 | 0.3666 |
| October 26, 2026 | 0.4535 |
| October 23, 2026 | 0.4881 |
| October 22, 2026 | 0.5026 |
| October 21, 2026 | 0.5094 |
| October 20, 2026 | 0.5124 |
| October 19, 2026 | 0.5076 |
| Date | Value |
|---|---|
| October 16, 2026 | 0.5144 |
| October 15, 2026 | 0.5434 |
| October 14, 2026 | 0.5419 |
| October 13, 2026 | 0.5946 |
| October 12, 2026 | 0.6351 |
| October 09, 2026 | 0.7279 |
| October 08, 2026 | 0.7548 |
| October 07, 2026 | 0.8228 |
| October 06, 2026 | 0.8379 |
| October 05, 2026 | 0.8574 |
| October 02, 2026 | 0.8491 |
| October 01, 2026 | 0.8695 |
| September 30, 2026 | 0.8958 |
| September 29, 2026 | 0.6186 |
| September 28, 2026 | 0.5985 |
| September 25, 2026 | 0.6132 |
| September 24, 2026 | 0.6787 |
| September 23, 2026 | 0.7543 |
| September 22, 2026 | 0.7165 |
| September 21, 2026 | 0.7495 |
| September 18, 2026 | 0.7298 |
| September 17, 2026 | 0.757 |
| September 16, 2026 | 0.7722 |
| September 15, 2026 | 0.7825 |
| September 14, 2026 | 0.7813 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
| Arrowhead Pharmaceuticals, Inc. | 116.18 |
Price to Book Value Related Metrics
| Price | 3.82 |
| Earnings Yield | -569.1% |
| Market Cap | 9.595M |